Frontera Therapeutics
PrivateLast Round
Series B
Jul 19, 2022
Total Funding Raised
$195M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Frontera Therapeutics operates in Healthcare & Life Sciences and is based in Bedford, Massachusetts. Its latest recorded funding round was a Series B round in July 2022.
Frontera Therapeutics is a biotechnology company that develops and commercializes recombinant adeno-associated virus (rAAV) gene therapies for the treatment of genetic disorders in ophthalmology, cardiology, and neurology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Frontera Therapeutics Comparables
Compare Frontera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exegenesis Bio | 86% | |
| Belief BioMed Inc. | 83% | |
| Avirmax, Inc. | 80% |
For institutional investors. Book with your work email.
Frontera Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Frontera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boyu Capital | Series B |
| Creacion Ventures | Series B, Series A |
| Starr Investment Holdings | Series B |
| OrbiMed | Series B, Series A |
| Starr Investments & Benefits | Series B |
| TMCP | Series B |
| HongShan Capital Group (HSG) | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 51% MoM.
- Apr 22, 2025
Will present gene therapy advances at the 2025 ASGCT Annual meeting.
For institutional investors. Book with your work email.
Frontera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Frontera Therapeutics's valuation, stock price, and market status.
Is Frontera Therapeutics a public or private company?
Frontera Therapeutics is a private company.
What is the current stock price of Frontera Therapeutics?
Frontera Therapeutics is a private company, so its shares have no public market price. Caplight tracks Frontera Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Frontera Therapeutics worth (valuation)?
Valuation information for Frontera Therapeutics is not publicly available.
Can I buy Frontera Therapeutics stock?
Frontera Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Frontera Therapeutics's last funding round?
Frontera Therapeutics's most recent funding round was Series B on July 19, 2022.
Who are the main investors in Frontera Therapeutics?
Key investors in Frontera Therapeutics include Boyu Capital, Creacion Ventures, OrbiMed, HongShan Capital Group (HSG).
Will Frontera Therapeutics IPO soon?
No public IPO plans have been announced for Frontera Therapeutics.
How can I track Frontera Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Frontera Therapeutics's shares on secondary markets.